Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Carson

Showing results (831-840 of 918) with videos related to

Pageof 92
Sort By:
Cancer Immunology Research|July 21, 2017
MICA-Expressing Monocytes Enhance Natural Killer Cell Fc Receptor-Mediated Antitumor FunctionsAmanda R Campbell, Megan C Duggan, Lorena P Suarez-Kelly, et al.
Oncotargets and Therapy|October 13, 2016
MicroRNA profiling of patient plasma for clinical trials using bioinformatics and biostatistical approachesJoseph Markowitz, Zachary Abrams, Naduparambil K Jacob, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
Trabectedin Enhances Oncolytic Virotherapy by Reducing Barriers to Virus Spread and Cytotoxic Immunity in Preclinical Pediatric Bone SarcomaEmily M Ringwalt, Mark A Currier, Andrea M Glaspell, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 17, 2022
Synaptic density and cognitive performance in Alzheimer's disease: A PET imaging study with [<sup>11</sup> C]UCB-JAdam P Mecca, Ryan S O'Dell, Emily S Sharp, et al.
Science Translational Medicine|November 1, 2023
Intrathecal delivery of nanoparticle PARP inhibitor to the cerebrospinal fluid for the treatment of metastatic medulloblastomaMinsoo Khang, Ju Hyun Lee, Teresa Lee, et al.
Molecular Psychiatry|June 25, 2026
Widespread synaptic density loss in schizophrenia follows molecular and network architectureSidhant Chopra, Patrick D Worhunsky, Mika Naganawa, et al.
Blood Advances|February 10, 2019
Anti-BAFF-R antibody VAY-736 demonstrates promising preclinical activity in CLL and enhances effectiveness of ibrutinibEmily M McWilliams, Christopher R Lucas, Timothy Chen, et al.
European Heart Journal|April 21, 2017
Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trialsAzmil H Abdul-Rahim, Ana-Cristina Perez, Rachael L MacIsaac, et al.
Molecular Therapy. Oncology|November 4, 2024
Trabectedin promotes oncolytic virus antitumor efficacy, viral gene expression, and immune effector function in models of bone sarcomaEmily M Ringwalt, Mark A Currier, Andrea M Glaspell, et al.
Journal of the American College of Cardiology|February 14, 1998
Design and baseline characteristics of the Veterans Affairs Non-Q-Wave Infarction Strategies In-Hospital (VANQWISH) trial. VANQWISH Trial Research InvestigatorsD R Ferry, R A O'Rourke, A S Blaustein, et al.
Pageof 92

Showing results (831-840 of 918) with videos related to

Sort By:
Pageof 92
Cancer Immunology Research|July 21, 2017
MICA-Expressing Monocytes Enhance Natural Killer Cell Fc Receptor-Mediated Antitumor FunctionsAmanda R Campbell, Megan C Duggan, Lorena P Suarez-Kelly, et al.
Oncotargets and Therapy|October 13, 2016
MicroRNA profiling of patient plasma for clinical trials using bioinformatics and biostatistical approachesJoseph Markowitz, Zachary Abrams, Naduparambil K Jacob, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
Trabectedin Enhances Oncolytic Virotherapy by Reducing Barriers to Virus Spread and Cytotoxic Immunity in Preclinical Pediatric Bone SarcomaEmily M Ringwalt, Mark A Currier, Andrea M Glaspell, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 17, 2022
Synaptic density and cognitive performance in Alzheimer's disease: A PET imaging study with [<sup>11</sup> C]UCB-JAdam P Mecca, Ryan S O'Dell, Emily S Sharp, et al.
Science Translational Medicine|November 1, 2023
Intrathecal delivery of nanoparticle PARP inhibitor to the cerebrospinal fluid for the treatment of metastatic medulloblastomaMinsoo Khang, Ju Hyun Lee, Teresa Lee, et al.
Molecular Psychiatry|June 25, 2026
Widespread synaptic density loss in schizophrenia follows molecular and network architectureSidhant Chopra, Patrick D Worhunsky, Mika Naganawa, et al.
Blood Advances|February 10, 2019
Anti-BAFF-R antibody VAY-736 demonstrates promising preclinical activity in CLL and enhances effectiveness of ibrutinibEmily M McWilliams, Christopher R Lucas, Timothy Chen, et al.
European Heart Journal|April 21, 2017
Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trialsAzmil H Abdul-Rahim, Ana-Cristina Perez, Rachael L MacIsaac, et al.
Molecular Therapy. Oncology|November 4, 2024
Trabectedin promotes oncolytic virus antitumor efficacy, viral gene expression, and immune effector function in models of bone sarcomaEmily M Ringwalt, Mark A Currier, Andrea M Glaspell, et al.
Journal of the American College of Cardiology|February 14, 1998
Design and baseline characteristics of the Veterans Affairs Non-Q-Wave Infarction Strategies In-Hospital (VANQWISH) trial. VANQWISH Trial Research InvestigatorsD R Ferry, R A O'Rourke, A S Blaustein, et al.
Pageof 92